期刊
RHEUMATOLOGY
卷 48, 期 10, 页码 1304-1308出版社
OXFORD UNIV PRESS
DOI: 10.1093/rheumatology/kep222
关键词
Schnitzler's syndrome; Autoinflammatory diseases; Inflammasome; Interleukin-1 beta; P2X(7) receptor
类别
资金
- Italian Association for Cancer Research, Telethon of Italy [GGP06070]
- Italian Space Agency (ASI-OSMA)
- Italian Ministry of University and Scientific Research (PRIN)
- Commission of European Communities [HEALTH-F2-2007-202231]
- Regione Emilia-Romagna
- Fondazione Cassa di Risparmio di Ferrara
- University of Ferrara
Objective. IL-1 beta plays a key role in the pathogenesis of Schnitzler's syndrome (SS). We have investigated inflammasome activity in peripheral blood mononuclear cells (PBMCs) from a patient affected by a variant type of SS. Methods. PBMCs were purified by Ficoll and examined for ability to secrete IL-1 beta and -18, expression and function of the P2X(7) receptor and expression of apoptosis-associated speck-like protein containing a caspase recruitment domaine (ASC) and NOD-like receptor protein 3 (NLRP3) before and after the therapy with steroid. Furthermore, extracellular adenosine 5'-triphosphate (ATP) blood levels were determined by luciferase assay. Expression of inflammasome components was measured by real time PCR and western blotting. Results. PBMCs of patient with SS showed a high, spontaneous and lipopolysaccharide-stimulated, IL-1 beta release but low response to stimulation with the P2X(7) agonist benzoyl ATP. P2X(7) expression was several fold increased, whereas ASC expression was dramatically decreased compared with PBMCs from healthy controls. NLRP3 expression was unchanged. Prednisone treatment induced remission of clinical symptoms and normalized IL-1 beta secretion and P2X(7) and ASC expression. Conclusion. These findings reveal the presence of an overall derangement of the inflammasome and IL-1 beta processing and release in SS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据